herbst and his colleagues first showed in 1971 that girls born to mothers who had taken diethylstilboestrol ( des ) during pregnancy were at an increased risk of clear-cell adenocarcinoma of the vagina and cervix .
C0012203
diethylstilboestrol
C0032961
pregnancy